Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | BTSG | BRIGHTSPRING HEALTH SVCS INC | Healthcare | 165,896.0 | $11.6M | 1.09% | +116K | +231.8% | $69.74 | -14.6% |
| 22 | MDT | MEDTRONIC PLC | Healthcare | 145,000.0 | $11.3M | 1.07% | +55K | +61.1% | $78.23 | +18.0% |
| 23 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 416,371.0 | $11.2M | 1.06% | +153K | +58.3% | $26.98 | -4.6% |
| 24 | ALGN | ALIGN TECHNOLOGY INC | Healthcare | 63,000.0 | $10.6M | 1.00% | +56K | +740.0% | $168.66 | -5.8% |
| 25 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 566,000.0 | $10.6M | 1.00% | +206K | +57.2% | $18.71 | +5.3% |
| 26 | A | AGILENT TECHNOLOGIES INC | Healthcare | 75,000.0 | $10.0M | 0.94% | +50K | +200.0% | $132.83 | +17.7% |
| 27 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 141,250.0 | $9.9M | 0.93% | +82K | +139.4% | $69.81 | +6.8% |
| 28 | ALKS | ALKERMES PLC | Healthcare | 185,250.0 | $9.7M | 0.92% | +52K | +39.0% | $52.40 | -8.4% |
| 29 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 86,127.0 | $8.4M | 0.79% | +4K | +5.5% | $97.48 | +12.3% |
| 30 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 145,100.0 | $7.8M | 0.73% | +17K | +13.3% | $53.67 | -5.9% |
| 31 | EHC | ENCOMPASS HEALTH CORP | Healthcare | 74,263.0 | $7.5M | 0.71% | +18K | +32.0% | $101.08 | +19.6% |
| 32 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 384,800.0 | $7.5M | 0.71% | +145K | +60.7% | $19.47 | -18.5% |
| 33 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 91,100.0 | $6.8M | 0.64% | +500.0 | +0.6% | $74.48 | +11.4% |
| 34 | KURA | KURA ONCOLOGY INC | Healthcare | 591,500.0 | $6.5M | 0.61% | +320K | +117.9% | $10.97 | +6.7% |
| 35 | PODD | INSULET CORP | Healthcare | 42,000.0 | $6.4M | 0.60% | +28K | +200.0% | $152.25 | -3.5% |
| 36 | STVN | STEVANATO GROUP S P A | Healthcare | 305,972.0 | $5.5M | 0.52% | +31K | +11.4% | $18.07 | +23.7% |
| 37 | CI | THE CIGNA GROUP | Healthcare | 17,400.0 | $4.8M | 0.45% | +9K | +117.5% | $275.68 | -0.5% |
| 38 | SION | SIONNA THERAPEUTICS INC | Healthcare | 97,100.0 | $4.3M | 0.40% | +10K | +11.0% | $43.99 | -87.5% |
| 39 | — | COOPER COS INC | — | 54,000.0 | $3.9M | 0.37% | +4K | +8.0% | $71.71 | — |
| 40 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 33,250.0 | $2.0M | 0.19% | +5K | +18.8% | $60.36 | -1.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%